131 related articles for article (PubMed ID: 9643018)
1. [Sorsby's fundus dystrophy. A genetically homogeneous disease].
Felbor U; Weber BH
Ophthalmologe; 1998 May; 95(5):287-90. PubMed ID: 9643018
[TBL] [Abstract][Full Text] [Related]
2. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
[TBL] [Abstract][Full Text] [Related]
3. Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation.
Felbor U; Benkwitz C; Klein ML; Greenberg J; Gregory CY; Weber BH
Arch Ophthalmol; 1997 Dec; 115(12):1569-71. PubMed ID: 9400791
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
[TBL] [Abstract][Full Text] [Related]
5. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
Li Z; Clarke MP; Barker MD; McKie N
Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
[TBL] [Abstract][Full Text] [Related]
6. Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance.
Felbor U; Suvanto EA; Forsius HR; Eriksson AW; Weber BH
Am J Hum Genet; 1997 Jan; 60(1):57-62. PubMed ID: 8981947
[TBL] [Abstract][Full Text] [Related]
7. Sorsby's fundus dystrophy in the British Isles: demonstration of a striking founder effect by microsatellite-generated haplotypes.
Wijesuriya SD; Evans K; Jay MR; Davison C; Weber BH; Bird AC; Bhattacharya SS; Gregory CY
Genome Res; 1996 Feb; 6(2):92-101. PubMed ID: 8919688
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.
Felbor U; Doepner D; Schneider U; Zrenner E; Weber BH
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1054-9. PubMed ID: 9152224
[TBL] [Abstract][Full Text] [Related]
9. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features.
Tabata Y; Isashiki Y; Kamimura K; Nakao K; Ohba N
Hum Genet; 1998 Aug; 103(2):179-82. PubMed ID: 9760202
[TBL] [Abstract][Full Text] [Related]
10. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
Lin RJ; Blumenkranz MS; Binkley J; Wu K; Vollrath D
Am J Ophthalmol; 2006 Nov; 142(5):839-48. PubMed ID: 16989765
[TBL] [Abstract][Full Text] [Related]
11. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
[TBL] [Abstract][Full Text] [Related]
12. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
[TBL] [Abstract][Full Text] [Related]
13. Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter.
Weber BH; Vogt G; Wolz W; Ives EJ; Ewing CC
Nat Genet; 1994 Jun; 7(2):158-61. PubMed ID: 7920634
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond.
Naessens S; De Zaeytijd J; Syx D; Vandenbroucke RE; Smeets F; Van Cauwenbergh C; Leroy BP; Peelman F; Coppieters F
Hum Mutat; 2019 May; 40(5):539-551. PubMed ID: 30668888
[TBL] [Abstract][Full Text] [Related]
15. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy.
Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ
J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594
[TBL] [Abstract][Full Text] [Related]
16. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
Soboleva G; Geis B; Schrewe H; Weber BH
J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
[TBL] [Abstract][Full Text] [Related]
17. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.
Langton KP; McKie N; Curtis A; Goodship JA; Bond PM; Barker MD; Clarke M
J Biol Chem; 2000 Sep; 275(35):27027-31. PubMed ID: 10854443
[TBL] [Abstract][Full Text] [Related]
18. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
Fogarasi M; Janssen A; Weber BH; Stöhr H
Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
[TBL] [Abstract][Full Text] [Related]
19. Sorsby's fundus dystrophy in two Japanese families with unusual clinical features.
Isashiki Y; Tabata Y; Kamimura K; Ohba N
Jpn J Ophthalmol; 1999; 43(6):472-80. PubMed ID: 10672875
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene.
Ayyagari R; Griesinger IB; Bingham E; Lark KK; Moroi SE; Sieving PA
Arch Ophthalmol; 2000 Jan; 118(1):85-92. PubMed ID: 10636420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
